Lafayette, Colorado Clinical Trials

A listing of Lafayette, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 59 clinical trials
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

This phase II/III trial studies how well circulating tumor deoxyribonucleic acid (ctDNA) testing in the blood works in predicting treatment for patients with stage IIA colon cancer after surgery. ctDNA are circulating tumor cells that are shed by tumors into the blood. Finding ctDNA in the blood means that there …

cancer
absolute neutrophil count
international normalized ratio
leucovorin
platelet count
Boulder Community Foothills Hospital
 (6.2 away) Contact site
  • 0 views
  • 23 Jul, 2022
  • +609 other locations
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may …

mitomycin
absolute neutrophil count
diabetes
metastatic melanoma
mdx-ctla-4
Kaiser Permanente-Rock Creek
 (0.5 away) Contact site
  • 162 views
  • 23 Jul, 2022
  • +423 other locations
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

This phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (time being alive) and progression-free survival (time being alive without cancer) for patients with intermediate risk human papillomavirus (HPV) positive oropharynx cancer (throat cancer) that has …

Boulder Community Hospital
 (7.6 away) Contact site
  • 428 views
  • 24 Jul, 2022
  • +456 other locations
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

This phase III trial compares immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients with newly diagnosed stage III or IV classic Hodgkin lymphoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the …

immunosuppressive
nivolumab
lymphoma
brentuximab
cell transplantation
Boulder Community Hospital
 (7.6 away) Contact site
  • 101 views
  • 24 Jul, 2022
  • +342 other locations
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell carcinoma that has spread to other parts of the body. The addition of cabozantinib to the …

pembrolizumab
pd-l1
step 2
programmed cell death 1 ligand 1
nivolumab
Kaiser Permanente-Rock Creek
 (0.2 away) Contact site
  • 319 views
  • 24 Jul, 2022
  • +348 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and …

carboplatin
pembrolizumab
paclitaxel
platelet count
pemetrexed
Boulder Community Hospital
 (7.0 away) Contact site
  • 136 views
  • 25 Jul, 2022
  • +467 other locations
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such …

ejection fraction
hepatitis b
estrogen receptor
progesterone receptor
pertuzumab
Boulder Community Foothills Hospital
 (6.2 away) Contact site
  • 92 views
  • 27 Jul, 2022
  • +639 other locations
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

This trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this trial have either spread to other parts of the body (metastatic) or cannot be removed completely with surgery (unresectable). …

fulvestrant
cancer chemotherapy
erbb2
trastuzumab
systemic therapy
Rocky Mountain Cancer Centers
 (7.9 away) Contact site
  • 27 views
  • 27 Jul, 2022
  • +60 other locations
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

This phase III trial studies how well an antibody (durvalumab) with chemotherapy and radiation therapy (chemoradiation) works in treating patients with stage III non-small cell lung cancer that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, …

carboplatin
paclitaxel
mitomycin
lung cancer
neutrophil count
Boulder Community Foothills Hospital
 (6.2 away) Contact site
  • 155 views
  • 28 Jul, 2022
  • +546 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

carboplatin
pembrolizumab
paclitaxel
crizotinib
nivolumab
Kaiser Permanente-Rock Creek
 (0.5 away) Contact site
  • 1154 views
  • 08 Aug, 2022
  • +1028 other locations